Report Detail

Other Global Continuous Glucose Monitoring (CGM) Market Insights, Forecast to 2025

  • RnM2365710
  • |
  • 16 May, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Other

Global Continuous Glucose Monitoring (CGM) Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Continuous Glucose Monitoring (CGM) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by Product
      • 1.4.2 Transmitters
      • 1.4.3 Sensors
      • 1.4.4 Insulin Pumps
    • 1.5 Market by End User
      • 1.5.1 Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Homecare Settings
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Continuous Glucose Monitoring (CGM) Market Size
      • 2.1.1 Global Continuous Glucose Monitoring (CGM) Revenue 2014-2025
      • 2.1.2 Global Continuous Glucose Monitoring (CGM) Sales 2014-2025
    • 2.2 Continuous Glucose Monitoring (CGM) Growth Rate by Regions
      • 2.2.1 Global Continuous Glucose Monitoring (CGM) Sales by Regions
      • 2.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Continuous Glucose Monitoring (CGM) Sales by Manufacturers
      • 3.1.1 Continuous Glucose Monitoring (CGM) Sales by Manufacturers
      • 3.1.2 Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers
      • 3.1.3 Global Continuous Glucose Monitoring (CGM) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Continuous Glucose Monitoring (CGM) Revenue by Manufacturers
      • 3.2.1 Continuous Glucose Monitoring (CGM) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Continuous Glucose Monitoring (CGM) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Continuous Glucose Monitoring (CGM) Price by Manufacturers
    • 3.4 Continuous Glucose Monitoring (CGM) Manufacturing Base Distribution, Product Types
      • 3.4.1 Continuous Glucose Monitoring (CGM) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Continuous Glucose Monitoring (CGM) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Continuous Glucose Monitoring (CGM) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Continuous Glucose Monitoring (CGM) Sales by Product
    • 4.2 Global Continuous Glucose Monitoring (CGM) Revenue by Product
    • 4.3 Continuous Glucose Monitoring (CGM) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Continuous Glucose Monitoring (CGM) Breakdown Data by End User

    6 North America

    • 6.1 North America Continuous Glucose Monitoring (CGM) by Countries
      • 6.1.1 North America Continuous Glucose Monitoring (CGM) Sales by Countries
      • 6.1.2 North America Continuous Glucose Monitoring (CGM) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Continuous Glucose Monitoring (CGM) by Product
    • 6.3 North America Continuous Glucose Monitoring (CGM) by End User

    7 Europe

    • 7.1 Europe Continuous Glucose Monitoring (CGM) by Countries
      • 7.1.1 Europe Continuous Glucose Monitoring (CGM) Sales by Countries
      • 7.1.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Continuous Glucose Monitoring (CGM) by Product
    • 7.3 Europe Continuous Glucose Monitoring (CGM) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Continuous Glucose Monitoring (CGM) by Countries
      • 8.1.1 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Countries
      • 8.1.2 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Continuous Glucose Monitoring (CGM) by Product
    • 8.3 Asia Pacific Continuous Glucose Monitoring (CGM) by End User

    9 Central & South America

    • 9.1 Central & South America Continuous Glucose Monitoring (CGM) by Countries
      • 9.1.1 Central & South America Continuous Glucose Monitoring (CGM) Sales by Countries
      • 9.1.2 Central & South America Continuous Glucose Monitoring (CGM) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Continuous Glucose Monitoring (CGM) by Product
    • 9.3 Central & South America Continuous Glucose Monitoring (CGM) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Continuous Glucose Monitoring (CGM) by Countries
      • 10.1.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Countries
      • 10.1.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Continuous Glucose Monitoring (CGM) by Product
    • 10.3 Middle East and Africa Continuous Glucose Monitoring (CGM) by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Continuous Glucose Monitoring (CGM) Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Baxter
      • 11.2.1 Baxter Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Baxter Continuous Glucose Monitoring (CGM) Products Offered
      • 11.2.5 Baxter Recent Development
    • 11.3 Abbott Laboratories
      • 11.3.1 Abbott Laboratories Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Products Offered
      • 11.3.5 Abbott Laboratories Recent Development
    • 11.4 Medtronic
      • 11.4.1 Medtronic Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Medtronic Continuous Glucose Monitoring (CGM) Products Offered
      • 11.4.5 Medtronic Recent Development
    • 11.5 Animas
      • 11.5.1 Animas Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Animas Continuous Glucose Monitoring (CGM) Products Offered
      • 11.5.5 Animas Recent Development
    • 11.6 Novo Nordisk
      • 11.6.1 Novo Nordisk Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Products Offered
      • 11.6.5 Novo Nordisk Recent Development
    • 11.7 Ypsomed
      • 11.7.1 Ypsomed Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Products Offered
      • 11.7.5 Ypsomed Recent Development
    • 11.8 GlySens
      • 11.8.1 GlySens Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 GlySens Continuous Glucose Monitoring (CGM) Products Offered
      • 11.8.5 GlySens Recent Development

    12 Future Forecast

    • 12.1 Continuous Glucose Monitoring (CGM) Market Forecast by Regions
      • 12.1.1 Global Continuous Glucose Monitoring (CGM) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Continuous Glucose Monitoring (CGM) Revenue Forecast by Regions 2019-2025
    • 12.2 Continuous Glucose Monitoring (CGM) Market Forecast by Product
      • 12.2.1 Global Continuous Glucose Monitoring (CGM) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Continuous Glucose Monitoring (CGM) Revenue Forecast by Product 2019-2025
    • 12.3 Continuous Glucose Monitoring (CGM) Market Forecast by End User
    • 12.4 North America Continuous Glucose Monitoring (CGM) Forecast
    • 12.5 Europe Continuous Glucose Monitoring (CGM) Forecast
    • 12.6 Asia Pacific Continuous Glucose Monitoring (CGM) Forecast
    • 12.7 Central & South America Continuous Glucose Monitoring (CGM) Forecast
    • 12.8 Middle East and Africa Continuous Glucose Monitoring (CGM) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Continuous Glucose Monitoring (CGM) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      A continuous glucose monitor is a device used for monitoring blood glucose on a continual basis by people with type I diabetes.
      A continuous glucose monitor takes a reading on set intervals with a small electrode placed under the skin and held in place by an adhesive. A transmitter attached to the electrode sends data to a separate receiver.
      The global Continuous Glucose Monitoring (CGM) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Continuous Glucose Monitoring (CGM) market based on company, product type, end user and key regions.

      This report studies the global market size of Continuous Glucose Monitoring (CGM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Continuous Glucose Monitoring (CGM) in these regions.
      This research report categorizes the global Continuous Glucose Monitoring (CGM) market by top players/brands, region, type and end user. This report also studies the global Continuous Glucose Monitoring (CGM) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Baxter
      Abbott Laboratories
      Medtronic
      Animas
      Novo Nordisk
      Ypsomed
      GlySens

      Market size by Product
      Transmitters
      Sensors
      Insulin Pumps
      Market size by End User
      Hospitals
      Homecare Settings
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Continuous Glucose Monitoring (CGM) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Continuous Glucose Monitoring (CGM) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Continuous Glucose Monitoring (CGM) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Continuous Glucose Monitoring (CGM) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Continuous Glucose Monitoring (CGM) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Continuous Glucose Monitoring (CGM) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Continuous Glucose Monitoring (CGM) . Industry analysis & Market Report on Continuous Glucose Monitoring (CGM) is a syndicated market report, published as Global Continuous Glucose Monitoring (CGM) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Continuous Glucose Monitoring (CGM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,864.30
      5,796.45
      7,728.60
      4,380.96
      6,571.44
      8,761.92
      536,986.10
      805,479.15
      1,073,972.20
      341,269.81
      511,904.72
      682,539.62
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report